More from the company: CHOSA Oncology AB presents at Stora Aktiedagarna in Stockholm

More from the company: CHOSA Oncology AB presenterar på Stora Aktiedagarna i Stockholm

Reports: CHOSA Onocology (före detta RhoVac AB) offentliggör bokslutskommuniké för verksamhetsåret 2022

More from the company: CHOSA team to participate at ASCO and present phase II data from the iCIP study

More from the company: CHOSA-teamet kommer delta på ASCO och presentera fas II-data från iCIP-studien

Market Notices: Market Notice 36/23 – RhoVac AB changes name to CHOSA Oncology AB

Market Notices: Market Notice 36/23 – RhoVac AB changes name to CHOSA Oncology AB

Press release from Companies: RhoVac AB changes name to CHOSA Oncology AB

Press release from Companies: RhoVac AB changes name to CHOSA Oncology AB

Press release from Companies: RhoVac AB byter namn till CHOSA Oncology AB

Press release from Companies: RhoVac AB byter namn till CHOSA Oncology AB

Press release from Companies: RhoVac AB (under name change to Chosa Oncology AB) has completed the acquisition of Chosa ApS and a new board and CEO have taken office